These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 6499739)

  • 21. [A comparative study of "in vitro" infectivity and "in vivo" leukemogenicity of Rauscher leukemia virus variants (author's transl)].
    Barbieri D; Barski G
    Ann Microbiol (Paris); 1973 Mar; 124(2):243-60. PubMed ID: 4583942
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of interferon treatment on the tumour-specific antibody response of BALB-c mice infected with Rauscher virus.
    Tóth FD; Váczi L; Berencsi C
    Acta Microbiol Acad Sci Hung; 1971; 18(2):109-12. PubMed ID: 4337368
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of Rauscher leukaemia virus on the immune system in susceptible and resistant mouse strains.
    Tóth FD; Karsai T; Váczi L
    Acta Microbiol Acad Sci Hung; 1971; 18(4):271-8. PubMed ID: 4136204
    [No Abstract]   [Full Text] [Related]  

  • 24. The development of specific cellular and humoral immunity in mice infected with Rauscher leukemia virus as neonates or adults.
    McCoy JL; Fefer A; Ting RC; Glynn JP
    Cancer Res; 1972 Aug; 32(8):1671-8. PubMed ID: 4339747
    [No Abstract]   [Full Text] [Related]  

  • 25. Protection of mice with recombinant influenza virus neuraminidase.
    Kilbourne ED; Pokorny BA; Johansson B; Brett I; Milev Y; Matthews JT
    J Infect Dis; 2004 Feb; 189(3):459-61. PubMed ID: 14745703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon and antibody production in inbred mice infected with the Rauscher virus.
    Tóth FD; Váczi L; Berencsi C
    Acta Microbiol Acad Sci Hung; 1971; 18(1):23-7. PubMed ID: 4335323
    [No Abstract]   [Full Text] [Related]  

  • 27. [Directed attacks on the specific activity of leukemia cells].
    Parfenov VV; Temarinova IuN; Balandin IG
    Biull Eksp Biol Med; 1977 Apr; 83(4):448-9. PubMed ID: 870111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioimmunoassay determination of two main cross-reacting viral antigens during radiation and Rauscher induced leukemias.
    Sassen A; Vander Plaetse F; Janowski M; Maisin JR
    Biomedicine; 1979 Jul; 30(3):147-55. PubMed ID: 486687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of tumor associated antigens by a producer and a nonproducer leukemia induced by Rauscher virus (R-MuLV).
    Chang KS; Liu W
    Cell Immunol; 1979 Feb; 42(2):373-83. PubMed ID: 427880
    [No Abstract]   [Full Text] [Related]  

  • 30. Serologically defined antigens on the surface of somatic hybrid cells.
    Rubio N
    Int Arch Allergy Appl Immunol; 1982; 67(2):123-6. PubMed ID: 7056591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Further studies on mouse fetal antigen cross-reactive with Rauscher leukemia.
    Ishimoto A; Suzuki Y; Yoshida T; Ito Y
    Cancer Res; 1974 Sep; 34(9):2338-43. PubMed ID: 4846102
    [No Abstract]   [Full Text] [Related]  

  • 32. Modulation of fetal antigen(s) in mouse leukemia cells.
    Ortaldo JR; Ting CC; Herberman RB
    Cancer Res; 1974 Jun; 34(6):1366-71. PubMed ID: 4545252
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of a Rauscher leukemia virus vaccine upon chemical oncogenesis in the mouse.
    Basombrío MA; Pasqualini CD
    Arch Geschwulstforsch; 1976; 46(8):630-3. PubMed ID: 1021012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Autogenic anti-idiotypic suppression of autoimmune reactions--a new approach to immunotherapy of experimental leukemia].
    Ter-Grigorov VS; Krupnik VE; Etkin AF; Pivnik AV; Moskovkina OIa
    Ter Arkh; 1985; 57(7):108-12. PubMed ID: 3863256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification of RNA-directed DNA polymerase from spleens of BALB/C mice infected with Rauscher leukemia virus [proceedings].
    Nijs G; Janowski M; Maisin JR
    Arch Int Physiol Biochim; 1978 May; 86(2):445-6. PubMed ID: 81021
    [No Abstract]   [Full Text] [Related]  

  • 36. [Characteristics of cellular and humoral immunity in mice infected with Rauscher leukemia virus following administration of serum against isologous aggregated immunoglobulins].
    Snegireva AE; Khorobrykh VV; Kaulen DR; Merimskaia OS; Shevliagin VIa
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1980; (7):27-33. PubMed ID: 6967739
    [No Abstract]   [Full Text] [Related]  

  • 37. Rauscher viral leukemogenesis in BALB/c mice treated with rabbit antimouse thymocyte serum.
    Siegel BV; Morton JI
    J Natl Cancer Inst; 1970 Mar; 44(3):573-9. PubMed ID: 11515425
    [No Abstract]   [Full Text] [Related]  

  • 38. The phagocytic activity of the reticuloendothelial system of mice infected by Rauscher leukemia virus.
    Seidel HJ; Nothdurft W
    J Reticuloendothel Soc; 1976 Mar; 19(3):173-82. PubMed ID: 1263188
    [No Abstract]   [Full Text] [Related]  

  • 39. Protective effect of specific immunization in Rauscher leukemia.
    Barski G; Youn JK
    Natl Cancer Inst Monogr; 1966 Sep; 22():659-69. PubMed ID: 5923334
    [No Abstract]   [Full Text] [Related]  

  • 40. Stimulation of murine lymphocytes by Rauscher leukemia virus in vitro.
    Bubbers JE; Elder JH; Dixon FJ
    J Immunol; 1980 Jan; 124(1):388-94. PubMed ID: 7350233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.